These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6377294)

  • 41. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy.
    Donga E; van Dijk M; Hoogma RP; Corssmit EP; Romijn JA
    Diabetes Metab Res Rev; 2013 Jan; 29(1):33-8. PubMed ID: 22936679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [THE EFFECTIVENESS OF PROLONGED-ACTION INSULIN USE IN DIABETES MELLITUS IN CHILDREN].
    MARTYNOVA MI; RYBINA LN
    Pediatriia; 1963 Aug; 42():14-9. PubMed ID: 14089146
    [No Abstract]   [Full Text] [Related]  

  • 43. Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials.
    Russell-Jones D; Gall MA; Niemeyer M; Diamant M; Del Prato S
    Nutr Metab Cardiovasc Dis; 2015 Oct; 25(10):898-905. PubMed ID: 26232910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Semilente-insulin at bedtime is superior to NPH-insulin for the suppression of the dawn-phenomenon in adolescents with type-I-diabetes.
    Holl RW; Teller WM; Heinze E
    Exp Clin Endocrinol Diabetes; 1996; 104(5):360-4. PubMed ID: 8957270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Insulin antibody titres--observations on their course in patients with diabetes mellitus. A case report].
    Grüneklee D; Takaishi T; Daweke H
    Munch Med Wochenschr; 1970 Jul; 112(27):1287-91. PubMed ID: 4193069
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparative evaluation of the hypoglycemic effect of the 2d-generation sulfonylurea preparations maninil and diamicron in diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Levitskaia ZI; Gincherman LE
    Probl Endokrinol (Mosk); 1982; 28(5):9-11. PubMed ID: 6815639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of juvenile diabetes mellitus.
    Chaney C; Elders MJ
    J Ark Med Soc; 1975 Aug; 72(3):111-27. PubMed ID: 125737
    [No Abstract]   [Full Text] [Related]  

  • 48. [Possibilities of therapy with various insulin preparations].
    Rabast R; Schönborn J
    Med Klin; 1976 Jun; 71(24):1023-30. PubMed ID: 933999
    [No Abstract]   [Full Text] [Related]  

  • 49. Treating to target in type 2 diabetes: the BEGIN trial programme.
    Wangnoo SK; Chowdhury S; Rao PV
    J Assoc Physicians India; 2014 Jan; 62(1 Suppl):21-6. PubMed ID: 25330628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin degludec (Tresiba)--a new long-acting insulin for diabetes.
    Med Lett Drugs Ther; 2015 Dec; 57(1483):163-4. PubMed ID: 26633683
    [No Abstract]   [Full Text] [Related]  

  • 51. [New insulin types in type 1 diabetes mellitus].
    Mesa J
    Med Clin (Barc); 2015 Jul; 145(2):70-5. PubMed ID: 25200067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
    Göbel P; Kramer W; Heni F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of the effectiveness of the use of insulin preparations in children with diabetes mellitus].
    Enikeev RG
    Pediatriia; 1973 Oct; 52(10):14-7. PubMed ID: 4783519
    [No Abstract]   [Full Text] [Related]  

  • 54. [The role of multiple insulin injections and self-monitoring of the disease in diabetes mellitus compensation in children].
    Kasatkina EP; Volkova TN; Matkovskaia AN; Demidova IIu; Artem'eva ID; Skorobogatova VF; Odud EA
    Probl Endokrinol (Mosk); 1990; 36(4):69-74. PubMed ID: 2235936
    [No Abstract]   [Full Text] [Related]  

  • 55. [Arfazetin in the treatment of diabetes mellitus].
    Korotkova VD; Perelygina AA; Trumpe TE; Sokolov SIa; Lobanova AM
    Probl Endokrinol (Mosk); 1988; 34(4):25-8. PubMed ID: 3057485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Degludec, a new ultra-long-acting basal insulin for the treatment of diabetes mellitus type 1 and 2: advances in clinical research.
    Muñoz Torres M
    Endocrinol Nutr; 2014 Mar; 61(3):153-9. PubMed ID: 23890782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical use of NPH insulin (author's transl)].
    Roesner M; Sauer H
    Dtsch Med Wochenschr; 1976 Jun; 101(23):886-9. PubMed ID: 1269430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type 1 diabetes mellitus and the use of flexible insulin regimens.
    Hirsch IB
    Am Fam Physician; 1999 Nov; 60(8):2343-52, 2355-6. PubMed ID: 10593324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Role of self-regulation in diabetic compensation in children and adolescents].
    Kasatkina EP; Demidova IIu; Matkovskaia AN; Volkova TN
    Probl Endokrinol (Mosk); 1986; 32(5):3-7. PubMed ID: 3786300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin sensitivity and 131-I insulin metabolism in juvenile-type diabetics.
    Martin FI; Stocks AE
    Australas Ann Med; 1967 Nov; 16(4):289-96. PubMed ID: 4169927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.